Alternative approaches have also identified that glypican-3 modulates the activity of the p38MAPK signalling pathway to the extent of inducing an EMT that would reverse the tumour cell phenotype and induce a reduced metastatic potential [98,99]. This evidence concerns the gene GPC3 and neoplasm.